Corporate
Dec. 13, 2012
Orrick guides 23andMe in $50 million fundraising round
Orrick, Herrington & Sutcliffe LLP advised genome sequencing company 23andMe in its $50 million Series D financing, further validating the industry's growth potential.
Daily Journal Staff Writer
Orrick, Herrington & Sutcliffe LLP represented 23andMe Inc. in its Series D financing of $50 million, announced Tuesday. The Mountain View-based company sells genome sequencing kits directly to consumers to use and return for lab analysis.
San Francisco-based corporate partner Karen Dempsey led the Orrick team, which included senior associate Amanda Galton, associate Scott M. Porter and paralegal A...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In